Holmes, EC; Twiddy, SS (maio de 2003). "The origin, emergence and evolutionary genetics of dengue virus.". Infection, Genetics and Evolution3 (1): 19–28. PMID12797969. doi:10.1016/s1567-1348(03)00004-2.
Jindadamrongwech, S.; Thepparit, C.; Smith, D. R. (maio de 2004). "Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2". Archives of Virology149 (5): 915–927. ISSN0304-8608. PMID15098107. doi:10.1007/s00705-003-0263-x.
Zidane, N; Dussart, P; Bremand, L; Villani, ME; Bedouelle, H (Jun 2013). "Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design". Protein Eng Des Sel26 (6): 389–399. PMID23479674. doi:10.1093/protein/gzt010.
Brandler, S; Ruffie, C; Najburg, V; Frenkiel, MP; Bedouelle, H; Desprès, P; Tangy, F (Sep 2010). "Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses". Vaccine28 (41): 6730–6739. PMID20688034. doi:10.1016/j.vaccine.2010.07.073.
Lisova, O; Hardy, F; Petit, V; Bedouelle, H (Sep 2007). "Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus". J Gen Virol88 (9): 2387–2397. PMID17698647. doi:10.1099/vir.0.83028-0.
Cockburn, JJ; Navarro Sanchez, ME; Fretes, N; Urvoas, A; Staropoli, I; Kikuti, CM; Coffey, LL; Arenzana Seisdedos, F; Bedouelle, H; Rey, FA (Feb 2012). "Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody". Structure20 (2): 303–314. PMID22285214. doi:10.1016/j.str.2012.01.001.
Lisova, O; Belkadi, L; Bedouelle, Hugues (Apr 2014). "Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus". J Mol Recognit27 (4): 205–214. PMID24591178. doi:10.1002/jmr.2352.
Diamond MS (setembro de 2009). "Mechanisms of evasion of the type I interferon antiviral response by flaviviruses". J. Interferon Cytokine Res.29 (9): 521–30. PMID19694536. doi:10.1089/jir.2009.0069.
Dwivedi, V. D., Tripathi, I. P., Tripathi, R. C., Bharadwaj, S., & Mishra, S. K. (2017). Genomics, proteomics and evolution of dengue virus. Briefings in functional genomics.16(4): 217–227, https://doi.org/10.1093/bfgp/elw040
Holmes, EC; Twiddy, SS (maio de 2003). "The origin, emergence and evolutionary genetics of dengue virus.". Infection, Genetics and Evolution3 (1): 19–28. PMID12797969. doi:10.1016/s1567-1348(03)00004-2.
Jindadamrongwech, S.; Thepparit, C.; Smith, D. R. (maio de 2004). "Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2". Archives of Virology149 (5): 915–927. ISSN0304-8608. PMID15098107. doi:10.1007/s00705-003-0263-x.
Zidane, N; Dussart, P; Bremand, L; Villani, ME; Bedouelle, H (Jun 2013). "Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design". Protein Eng Des Sel26 (6): 389–399. PMID23479674. doi:10.1093/protein/gzt010.
Brandler, S; Ruffie, C; Najburg, V; Frenkiel, MP; Bedouelle, H; Desprès, P; Tangy, F (Sep 2010). "Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses". Vaccine28 (41): 6730–6739. PMID20688034. doi:10.1016/j.vaccine.2010.07.073.
Lisova, O; Hardy, F; Petit, V; Bedouelle, H (Sep 2007). "Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus". J Gen Virol88 (9): 2387–2397. PMID17698647. doi:10.1099/vir.0.83028-0.
Cockburn, JJ; Navarro Sanchez, ME; Fretes, N; Urvoas, A; Staropoli, I; Kikuti, CM; Coffey, LL; Arenzana Seisdedos, F; Bedouelle, H; Rey, FA (Feb 2012). "Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody". Structure20 (2): 303–314. PMID22285214. doi:10.1016/j.str.2012.01.001.
Lisova, O; Belkadi, L; Bedouelle, Hugues (Apr 2014). "Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus". J Mol Recognit27 (4): 205–214. PMID24591178. doi:10.1002/jmr.2352.
Diamond MS (setembro de 2009). "Mechanisms of evasion of the type I interferon antiviral response by flaviviruses". J. Interferon Cytokine Res.29 (9): 521–30. PMID19694536. doi:10.1089/jir.2009.0069.
"Dengue virus". Pathogen Information (PathInfo). Virginia Bioinformatics Institute, Virginia Tech. Arquivado dende o orixinal o 30 de agosto de 2010. Consultado o 18 de xaneiro de 2018.
"Dengue virus". Pathogen Information (PathInfo). Virginia Bioinformatics Institute, Virginia Tech. Arquivado dende o orixinal o 30 de agosto de 2010. Consultado o 18 de xaneiro de 2018.
Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M. (agosto de 2010). "Dengue virus life cycle: viral and host factors modulating infectivity". Cellular and Molecular Life Sciences67 (16): 2773–2786. ISSN1420-682X. PMID20372965. doi:10.1007/s00018-010-0357-z.
Jindadamrongwech, S.; Thepparit, C.; Smith, D. R. (maio de 2004). "Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2". Archives of Virology149 (5): 915–927. ISSN0304-8608. PMID15098107. doi:10.1007/s00705-003-0263-x.